Pacific Backbone validators began earning third-party fees this quarter.
HSDT Solana Company
XNAS
2.48
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
HSDT
$2.48
—
What changed
Recent filings, trades and movesKey stats
$2.48
- 52-Week Range
- $1.19 – $4.93
- YTD
- -19.90%
- IV Rank (30D)
- 40.61
- Straddle Price
- $3.02
- P/C Vol Ratio
- 0.09
- Market Cap
- $0.1B
- Open
- $1.85
- Day Range
- $1.73 – $1.87
- Volume
- 490,767
- Prev Close
- $1.89
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.88% |
| Beta vs SPY | 1.01 |
| Cost of Equity (CAPM) | 10.44% (VRP-adj) |
| WACC | 10.47% |
| Volatility Risk Premium | +219.8pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +30.0% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -95.0% |
| Book / Price | 136.5% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 94.2% |
| FCF Margin (TTM) | -281.0% |
| Debt / Equity | 0.00 |
| Quality Score | 3/6 — normal (10y DCF) |
| SMA 50 | $2.36 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $2.11 |
| Bollinger Width / SMA20 | 32.0% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
Peers used for multiples: COIN, CRCL, MSTR, NU, SOFI, SYF
(filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$4.53
Deviation
+50.0%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 18.7× · 5 peers |
| Peer EV/EBITDA | n/a | 0% | median 9.1× · 5 peers |
| Peer P/B | $5.80 | 75% | median 2.2× · 6 peers |
| Peer P/S | $0.72 | 25% | median 5.2× · 6 peers |
| Market Anchor (SMA50) | $2.36 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-11-13 · updated
Related
About
- Industry (SIC)
- FINANCE SERVICES (6199) · industry map
- Exchange
- XNAS
- Market Cap
- $0.1B
- Employees
- 21
- List Date
- 2014-06-27
- CIK
- 0001610853
- Last Earnings
- Nov 11 before open · +2.2% vs ±198.6% expected
- Headquarters
- Philadelphia, PA
- Homepage
- https://www.solanacompany.co
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 19.32% | -29.01% | 18.75% | -17.66% | 6.78% | -11.00% | -2.14% |
| Feb | 3.26% | 14.29% | -25.54% | -31.82% | -33.30% | -24.90% | -16.33% |
| Mar | 29.38% | -23.91% | -11.50% | 27.85% | -9.68% | -18.40% | -1.04% |
| Apr | -5.79% | -7.76% | -21.73% | -29.00% | -45.33% | 20.00% | -14.94% |
| May | -21.23% | -47.86% | -15.30% | -60.83% | 4.96% | -10.14% | -25.07% |
| Jun | 24.29% | -40.40% | 26.80% | -30.00% | -95.02% | -5.44% | -19.96% |
| Jul | -5.64% | -34.36% | 10.53% | -26.41% | -19.60% | -5.98% | -13.58% |
| Aug | -6.07% | -25.82% | -34.05% | 10.18% | 0.33% | 31.55% | -3.98% |
| Sep | -0.60% | -47.92% | 28.59% | -34.46% | 144.50% | 25.36% | 19.25% |
| Oct | 1.21% | -1.57% | -22.22% | -2.42% | -60.29% | -20.23% | -17.59% |
| Nov | -52.69% | 13.45% | -17.27% | -3.46% | -20.80% | -14.14%* | -15.82% |
| Dec | -10.36% | 0.43% | 23.30% | 8.60% | -22.73% | -- | -0.15% |
| Total | -44.40% | -94.97% | -51.08% | -92.40% | -99.12% | -40.94% | -70.49% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $2.09
SMA 50: $2.35
SMA 200: $2.04
Current: $1.73
EMA 12: $1.96
EMA 26: $2.11
MACD: -0.1508 | Signal: -0.0284
BEARISH
ADX (14): 27.29
TREND
+DI: 12.26
−DI: 29.51
Momentum Oscillators
RSI (14): 29.48
OVERSOLD
Stoch %K: 15.73
Stoch %D: 15.18
Williams %R: -96.75
Volume & Volatility
BB Upper: $2.46
BB Lower: $1.72
NEUTRAL
OBV: 27,421,621
Vol SMA 20: 601,891
Vol ROC: -12.74%
ATR: $0.15
True Range: $0.16
HV 20: 61.1%
HV 30: 59.8%
HV 60: 93.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-15T00:00:00 – 2026-11-13T00:00:00
AI Analysis
Written before HSDT’s Nov 11 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers and Primary Risks:
- Technical indicators suggest a bearish trend, with a MACD signal indicating a potential sell signal.
- Recent news headlines are overwhelmingly positive, highlighting FDA submissions and strong enrollment numbers for the PoNS device.
- Volatility is high, with a beta of 1.69, indicating that the stock moves more than the market.
Investment Thesis:
The current technical picture suggests a bearish trend, but recent news headlines highlight the potential for future growth. The positive sentiment surrounding the FDA submissions and strong enrollment numbers could lead to increased investor interest and higher prices in the coming weeks.
Recent News Sentiment Impact:
- Positive news headlines have driven sentiment, leading to an increase in price.
- Further positive news or developments could continue this upward momentum.
- However, a lack of concrete data or setbacks in FDA submissions could lead to decreased sentiment and downward pressure on the stock.
Technical Analysis
Trend Direction: BEARISH (Short-term: 1-4 weeks), NEUTRAL (Medium-term: 1-3 months)
Support/Resistance Levels:
- SMA 20: $2.05
- SMA 50: $2.20
- Upper Bollinger Band: $2.36
Momentum Signals:
- RSI (14): Neutral at 42.91
- MACD: Bearish signal with a histogram of -0.10
- Stochastic %K/D: Neutral, but trending downwards
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines surrounding FDA submissions and strong enrollment numbers for the PoNS device.
Sentiment Assessment: POSITIVE (Aggregate sentiment from last 10 news articles)
Catalyst Identification: Upcoming FDA decisions and potential product launches could drive future growth.
Risk & Volatility Assessment
Beta Interpretation: HIGH RISK (Beta of 1.69, indicating that the stock moves more than the market)
Volatility Regime: High volatility, with an average true range of $0.21 and a volume rate of change of 76.96%.
Options Market Signals:
- IV Rank: Low at 5.8%
- Current IV: 200.9%
- Put/Call Volume Ratio: Bearish at 2.50
Market Context & Positioning
Sector Performance: The healthcare sector is relatively strong, with a correlation of 0.15 to the overall market.
Institutional Activity: Institutional investors are showing some interest in the stock, with an IV rank of low and a put/call volume ratio indicating bearish sentiment.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $2.05
- Upper Bollinger Band: $2.36
Breakout/Breakdown Levels: A breakout above the upper Bollinger Band could indicate a return to uptrend, while a breakdown below the SMA 20 could signal further bearish pressure.
Time-Sensitive Catalysts: Upcoming FDA decisions and potential product launches could drive future growth or volatility.
Risk Management:
- Stop-loss levels should be set at the SMA 20 ($2.05) to limit potential losses.
- Position sizing considerations should take into account the high volatility and potential for large price movements.
By analyzing the data, we can see that the technical indicators suggest a bearish trend, while the recent news headlines highlight positive developments surrounding the PoNS device. The options market signals indicate a low IV rank and a put/call volume ratio indicating bearish sentiment. Overall, the analysis suggests a neutral stance, with potential for further growth or volatility depending on future news and developments.
Generated
News
All HSDT news →
Earnings History
5 of 5 under expected move
Avg Expected Move
76.96%
Avg Actual Move
4.27%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2025-11-18 | Pre-Market | 65.12% | 6.98% | 0.11x | Within |
| 2026-03-30 | Pre-Market | 46.88% | 3.12% | 0.07x | Within |
| 2026-05-15 | Pre-Market | 49.16% | 3.77% | 0.08x | Within |
| 2026-08-14 | Pre-Market | 25.00% | 5.56% | 0.22x | Within |
| 2026-11-11 | Pre-Market | 198.63% | 1.92% | 0.01x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
HSDT Options Activity & IV Rank
HSDT IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 313.9%
7-DTE IV: 313.9%
Expected Move: $3.02
7-DTE Move: $2.40
Days to Exp: 35 (2026-12-18)
Options Flow · All expiries
Call Volume: 387
Put Volume: 35
P/C Volume: 0.09
BULLISH
Call OI: 9,482
Put OI: 407
P/C OI: 0.043
Total OI: 9,889
ATM Options Pricing
ATM Call: $1.75
ATM Put: $1.27
Call %: 70.7%
Put %: 51.5%
Chain Summary
Chain Volume: 422
Chain OI: 9,889
Last Updated: 11/13/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 83rd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
83%
vs own history
GEX tilt
+0.92
OI-weighted, today
Vanna tilt
+0.92
δ-sensitivity to IV
Charm tilt
-0.92
δ-decay vs time
Vanna tilt +0.92: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.92: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 3 ATM contracts, 1k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Put vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol pointsThe same measure on the upside: how the OTM call is priced against the at-the-money strike.
- Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
- Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together
Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put
—
—
pts
EXTREME
as of Nov 13 · No data
30 DTE / 10d put
—
—
pts
EXTREME
as of Nov 13 · ATM 177.4% / Put —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)45.4MediumNov 13
IV Rank (30 DTE)40.6MediumNov 13
Straddle Price (30 DTE)$3.02Nov 13
Beta Analysis
Risk Metrics
Beta: 2.8025
Alpha: -93.94%
Correlation: 0.3949
R-Squared: 15.6%
Stock Volatility: 96.8%
Market Volatility: 13.6%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own HSDT
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Rockefeller Capital Management Family office Rockefeller family | $404K | #2202 of 4729 | -29.0% | 13F | |
| Citadel Hedge fund Ken Griffin | $99K | #5809 of 6285 | new | 13F | |
| Millennium Management Hedge fund Izzy Englander | $97K | #3619 of 3716 | +0.6% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
HSDT Institutional Ownership (13F)
Filings for 2026-06-30 · 9 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 61,137,763 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
2 filers$130.51K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $89.59K | 68.65% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $40.92K | 31.35% | 2026-06-30 |
1 filers$23.10K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $23.10K | 100.00% | 2026-06-30 |
HSDT Insider Trading (Form 4)
Latest: 2026-08-24Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | Agustina Gani Tjandrasuwita | See Remarks | Grant (A) | +88,817 opt | — | EDGAR | |
| 2026-08-04 | Choon Wee Chee | CEO and President | Grant (A) | +923,000 opt | — | EDGAR | |
| 2026-07-13 | Summer Wisdom Holdings Ltd | 10%+ Owner | Other (J) | −1,453,277 | — | EDGAR | |
| 2026-06-04 | Cosmo Yi Jiang | Director | Grant (A) | +1,005,040 RSU | — | EDGAR | |
| 2026-06-04 | Cosmo Yi Jiang | Director | Mixed Exer +1,005,040 · Tax −610 |
+1,004,430 | $0.00 | -$1 | EDGAR |
| 2026-05-26 | Sergio Mello | Director | Award (A) | +6,360 | — | EDGAR | |
| 2026-05-26 | Blane Walter | Director | Award (A) | +2,180 | — | EDGAR | |
| 2026-05-26 | Edward M Straw | Director | Award (A) | +2,180 | — | EDGAR | |
| 2026-05-26 | Blane Walter | Director | Award (A) | +6,360 | — | EDGAR | |
| 2026-05-26 | Edward M Straw | Director | Award (A) | +6,360 | — | EDGAR | |
| 2026-05-26 | Michel Kai Tai Lee | Director | Award (A) | +6,360 | — | EDGAR | |
| 2026-05-22 | Fusion Summer Ltd | 10%+ Owner | Other (J) | −1,453,277 | — | EDGAR | |
| 2026-05-13 | Choon Wee Chee | Executive Chairman | Exer (M) | +1,109,118 | — | EDGAR | |
| 2026-04-02 | Blane Walter | Director | Award (A) | +2,180 | — | EDGAR | |
| 2026-04-02 | Paul Buckman | Director | Award (A) | +2,180 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
HSDT Insider Holdings
11 insiders · @ $1.73
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Choon Wee Chee | CEO and President | 6,486,243 | $11.22M | $0 | 2 | 2026-08-04 |
| 2 | Fusion Summer Ltd | 10%+ Owner | 5,377,125 | $9.30M | $0 | 1 | 2026-05-22 |
| 3 | Summer Wisdom Holdings Ltd | 10%+ Owner | 5,377,125 | $9.30M | $0 | 1 | 2026-07-13 |
| 4 | Cosmo Yi Jiang | Director | 1,004,430 | $1.74M | $0 | 2 | 2026-06-04 |
| 5 | Sherrie L Perkins | Director | 92,220 | $159.5K | $0 | 7 | 2026-04-02 |
| 6 | Paul Buckman | Director | 92,004 | $159.2K | $0 | 7 | 2026-04-02 |
| 7 | Edward M Straw | Director | 8,542 | $14.8K | $0 | 14 | 2026-05-26 |
| 8 | Blane Walter | Director | 8,542 | $14.8K | $0 | 14 | 2026-05-26 |
| 9 | Michel Kai Tai Lee | Director | 6,360 | $11.0K | $0 | 1 | 2026-05-26 |
| 10 | Sergio Mello | Director | 6,360 | $11.0K | $0 | 1 | 2026-05-26 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
HSDT Board & Officers
As of SEC filings through Aug 24, 2026Directors 7
- Edward M Straw · since May 14, 2015
- Blane Walter · since Dec 29, 2015
- Dane Andreeff · since Aug 4, 2017
- Choon Wee Chee · since Sep 18, 2025
- Cosmo Yi Jiang · since Oct 30, 2025
- Michel Kai Tai Lee · since Apr 23, 2026
- Sergio Mello · since Apr 23, 2026
Officers 4
- Dane Andreeff · President and CEO · listed since Jun 2021
- Jeffrey S Mathiesen · CFO and Treasurer · listed since Jun 2021
- Agustina Gani Tjandrasuwita · COO & Deputy CFO · since Apr 6, 2026
- Choon Wee Chee · Executive Chairman · listed since May 2026
10% owners 4
- Choon Wee Chee · since Sep 18, 2025
- Dane Andreeff · listed since Jun 2021
- Fusion Summer Ltd (entity) · since Sep 18, 2025
- Summer Wisdom Holdings Ltd (entity) · since Sep 18, 2025
Changes in the last 10 years (32)
| May 13, 2026 | Choon Wee Chee first listed as Executive Chairman in an SEC filing |
| Apr 23, 2026 | Sergio Mello became a director |
| Apr 23, 2026 | Michel Kai Tai Lee became a director |
| Apr 22, 2026 | The company announced the departure of Sherrie L Perkins from the board in an SEC filing |
| Apr 22, 2026 | The company announced the departure of Paul Buckman from the board in an SEC filing |
| Apr 8, 2026 | The company announced the departure of Pelt Antonella R. Favit-Van as Chief Medical Officer in an SEC filing |
| Apr 6, 2026 | Agustina Gani Tjandrasuwita became COO & Deputy CFO |
| Oct 30, 2025 | The company announced the departure of Jeffrey S Mathiesen from the board in an SEC filing |
| Oct 30, 2025 | The company announced the departure of Jeffrey S Mathiesen from the board in an SEC filing |
| Oct 30, 2025 | Cosmo Yi Jiang became a director |
| Sep 18, 2025 | Summer Wisdom Holdings Ltd became a 10% owner |
| Sep 18, 2025 | Fusion Summer Ltd became a 10% owner |
| Sep 18, 2025 | Choon Wee Chee became a director |
| Sep 18, 2025 | Choon Wee Chee became a 10% owner |
| Sep 14, 2022 | Jeffrey S Mathiesen first listed as a director in an SEC filing |
| Mar 8, 2022 | The company announced the departure of Mitch E Tyler from the board in an SEC filing |
| Sep 10, 2021 | Paul Buckman became a director |
| Jul 6, 2021 | Pelt Antonella R. Favit-Van became Chief Medical Officer |
| Jun 15, 2021 | Jeffrey S Mathiesen first listed as CFO and Treasurer in an SEC filing |
| Jun 15, 2021 | Dane Andreeff listed as President and CEO (previously Interim President and CEO) in SEC filings |
| Jun 15, 2021 | Dane Andreeff first listed as a 10% owner in an SEC filing |
| Mar 15, 2021 | Sherrie L Perkins became a director |
| Oct 26, 2020 | Dane Andreeff first listed as Interim President and CEO in an SEC filing |
| Jun 10, 2020 | Jeffrey S Mathiesen became a director |
| Jul 9, 2018 | Jennifer Laux became Chief Commercial Officer |
| May 17, 2018 | Jonathan Sackier no longer listed as a 10% owner in SEC filings |
| Dec 26, 2017 | Philippe Deschamps no longer listed as a 10% owner in SEC filings |
| Aug 4, 2017 | Dane Andreeff became a director |
| Apr 19, 2017 | Philippe Deschamps first listed as a 10% owner in an SEC filing |
| Apr 19, 2017 | Joyce N LaViscount no longer listed as a director in SEC filings |
| Apr 19, 2017 | Jonathan Sackier no longer listed as a director in SEC filings |
| Apr 19, 2017 | Jonathan Sackier first listed as a 10% owner in an SEC filing |
Not reported recently (6)
- Joyce N LaViscount · Last reported as CFO and COO in an SEC filing dated Apr 5, 2021
- Jonathan Sackier · Last reported as Chief Medical Officer in an SEC filing dated Oct 7, 2020
- Philippe Deschamps · Last reported as a director in an SEC filing dated May 1, 2020
- Huaizheng Peng · Last reported as a director in an SEC filing dated Dec 16, 2019
- Thomas E Griffin · Last reported as a director in an SEC filing dated Dec 16, 2019
- Jennifer Laux · Last reported as Chief Commercial Officer in an SEC filing dated Jul 11, 2018
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
Recent SEC Filings
Latest: 2026-11-12
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
3 ETFs hold HSDT
3 shown · $5.35M total exposure · 0.02% AUM-weighted avg weight
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-30.36
TTM Revenue
$12.07M
TTM Net Income
$-157.27M
TTM Op. Cash Flow
$-26.94M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $2.53M | $-30.26M | $-0.38 | $-11.89M |
| Q1 '26 | 2026-03-31 | $3.62M | $-99.80M | $-1.30 | $-4.83M |
| Q4 '25 | 2025-12-31 | $5.23M | $325.55M | $4.21 | $-6.18M |
| Q3 '25 | 2025-09-30 | $697.00K | $-352.77M | $-32.89 | $-4.04M |
| Q2 '25 | 2025-06-30 | $43.00K | $-9.83M | $-79.73 | $-2.76M |
| Q1 '25 | 2025-03-31 | $49.00K | $-3.84M | $-382.29 | $-3.54M |
| Q4 '24 | 2024-12-31 | $152.00K | $-3.93M | $2503.37 | $-2.38M |
| Q3 '24 | 2024-09-30 | $51.00K | $-3.69M | $-744.35 | $-2.77M |
| Q2 '24 | 2024-06-30 | $182.00K | $-1.61M | $-485.30 | $-2.89M |
| Q1 '24 | 2024-03-31 | $135.00K | $-2.52M | $-2310.00 | $-3.00M |
| Q4 '23 | 2023-12-31 | $134.00K | $-1.04M | $-0.96 | $-2.03M |
| Q3 '23 | 2023-09-30 | $143.00K | $-3.66M | $-5.49 | $-2.45M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-14
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
0.64
P/S
8.76
EV/EBITDA
—
EV/Sales
8.46
ROE
-94.9%
ROA
-89.3%
Div Yield
0.00%
FCF Yield
-25.47%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$105.77M
as of 2026-11-13
HSDT vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AXP American Express Company | $213.3B | 18.1 | +8.7% | −14.0% | 29 |
| NU Nu Holdings Ltd. | $57.1B | 20.3 | — | −22.3% | 27 |
| MSTR Strategy Inc Common Stock Class A | $48.4B | — | +0.4% | −29.0% | 47 |
| COIN Coinbase Global, Inc. Class A Common Sto | $34.6B | — | −26.6% | −46.0% | 26 |
| SYF SYNCHRONY FINANCIAL | $22.3B | 7.5 | +0.5% | −14.6% | 56 |
| SOFI SoFi Technologies, Inc. Common Stock | $20.3B | 32.1 | +59.1% | −43.8% | 26 |
| CRCL Circle Internet Group, Inc. | $16.4B | 31.9 | +46.0% | −25.5% | 13 |
| COOP Mr. Cooper Group Inc. Common Stock | $13.5B | — | — | +0.0% | — |
| HSDT Solana Company Class A Common Stock (DE) | $123M | — | +3992.2% | −44.0% | 41 |
| Peer median | $28.5B | 20.3 | +4.6% | −23.9% | 27 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.42M
SI % of Float
7.61%
Days to Cover
7.89
Short Vol Ratio
57.8%
Free Float
44.98M
Float %
74.4%
Short interest 2026-10-30 • Short volume 2026-11-13 • Float 2026-09-15